The aryl hydrocarbon receptor (AhR) 1661G>A polymorphism in human cancer: A meta-analysis

Gene

Volumn 513, Issue 1, 2013, Pages 225-230

  Luo, Chengzhang ^a   Zou, Peng ^a   Ji, Guixiang ^b,c   Gu, Aihua ^b   Zhao, Peng ^a   Zhao, Chunsheng ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c NANJING INSTITUTE OF ENVIRONMENTAL SCIENCES   (China)

Author keywords

AhR; Arg; Aryl hydrocarbon receptor; Cancer; CI; Lys; Meta analysis; OR; Polymorphism

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR;

ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER RISK; COLORECTAL CANCER; DNA POLYMORPHISM; ETHNICITY; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOTE; HUMAN; LUNG CANCER; NEOPLASM; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SYSTEMATIC REVIEW;

CASE-CONTROL STUDIES; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HOMOZYGOTE; HUMANS; MALE; NEOPLASMS; POLYMORPHISM, GENETIC; PUBLICATION BIAS; RECEPTORS, ARYL HYDROCARBON; RISK;

EID: 84872390331     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.09.050     Document Type: Article

References (32)

1. Barouki R., Coumoul X., Fernandez-Salguero P.M. The aryl hydrocarbon receptor, more than a xenobiotic-interacting protein. FEBS Lett. 2007, 581:3608-3615.
2. Berman N.G., Parker R.A. Meta-analysis: neither quick nor easy. BMC Med. Res. Methodol. 2002, 2:10.
3. Bock K.W., Kohle C. Ah receptor: dioxin-mediated toxic responses as hints to deregulated physiologic functions. Biochem. Pharmacol. 2006, 72:393-404.
4. Cauchi S., et al. Polymorphisms of human aryl hydrocarbon receptor (AhR) gene in a French population: relationship with CYP1A1 inducibility and lung cancer. Carcinogenesis 2001, 22:1819-1824.
5. Celius T., Matthews J. Functional analysis of six human aryl hydrocarbon receptor variants in human breast cancer and mouse hepatoma cell lines. Toxicology 2010, 277:59-65.
6. Chen Y.W., et al. Association of polymorphisms in AhR, CYP1A1, GSTM1, and GSTT1 genes with levels of DNA damage in peripheral blood lymphocytes among coke-oven workers. Cancer Epidemiol. Biomarkers Prev. 2006, 15:1703-1707.
7. Chen D., et al. Association of human aryl hydrocarbon receptor gene polymorphisms with risk of lung cancer among cigarette smokers in a Chinese population. Pharmacogenet. Genomics 2009, 19:25-34.
8. Cotterchio M., Boucher B.A., Manno M., Gallinger S., Okey A.B., Harper P.A. Red meat intake, doneness, polymorphisms in genes that encode carcinogen-metabolizing enzymes, and colorectal cancer risk. Cancer Epidemiol. Biomarkers Prev. 2008, 17:3098-3107.
9. Crews S.T. Control of cell lineage-specific development and transcription by bHLH-PAS proteins. Genes Dev. 1998, 12:607-620.
10. Daly A.K., Fairbrother K.S., Smart J. Recent advances in understanding the molecular basis of polymorphisms in genes encoding cytochrome P450 enzymes. Toxicol. Lett. 1998, 102-103:143-147.
11. De Roos A.J., et al. Metabolic gene variants and risk of non-Hodgkin's lymphoma. Cancer Epidemiol. Biomarkers Prev. 2006, 15:1647-1653.
12. de Waard P.W., et al. Influence of TCDD and natural Ah receptor agonists on benzo[a]pyrene-DNA adduct formation in the Caco-2 human colon cell line. Mutagenesis 2008, 23:67-73.
13. Egger M., Davey S.G., Schneider M., Minder C. Bias in Meta-Analysis Detected by a Simple, Graphical Test 1997.
14. Gonzalez F.J., Fernandez-Salguero P. The aryl hydrocarbon receptor. Studies Using the AHR-Null Mice 1998.
15. Harper P.A., Wong J.Y., Lam M.S., Okey A.B. Polymorphisms in the human AH receptor. Chem. Biol. Interact. 2002, 141:161-187.
16. Kawajiri K., et al. Polymorphisms of human Ah receptor gene are not involved in lung cancer. Pharmacogenetics 1995, 5:151-158.
17. Kim J.H., et al. Aryl hydrocarbon receptor gene polymorphisms affect lung cancer risk. Lung Cancer 2007, 56:9-15.
18. Ko H.P., Okino S.T., Ma Q., Whitlock J.J. Transactivation domains facilitate promoter occupancy for the dioxin-inducible CYP1A1 gene in vivo. Mol. Cell. Biol. 1997, 17:3497-3507.
19. Le Marchand L., Donlon T., Kolonel L.N., Henderson B.E., Wilkens L.R. Estrogen metabolism-related genes and breast cancer risk: the multiethnic cohort study. Cancer Epidemiol. Biomarkers Prev. 2005, 14:1998-2003.
20. Long J.R., et al. Population-based case-control study of AhR (aryl hydrocarbon receptor) and CYP1A2 polymorphisms and breast cancer risk. Pharmacogenet. Genomics 2006, 16:237-243.
21. Long J.R., Cai Q., Shu X.O., Cai H., Gao Y.T., Zheng W. Genetic polymorphisms in estrogen-metabolizing genes and breast cancer survival. Pharmacogenet. Genomics 2007, 17:331-338.
22. Marlowe J.L., Puga A. Aryl hydrocarbon receptor, cell cycle regulation, toxicity, and tumorigenesis. J. Cell. Biochem. 2005, 96:1174-1184.
23. Ng C.H., et al. Interaction between organochlorines and the AHR gene, and risk of non-Hodgkin lymphoma. Cancer Causes Control 2010, 21:11-22.
24. Pharoah P.D., Dunning A.M., Ponder B.A., Easton D.F. Association studies for finding cancer-susceptibility genetic variants. Nat. Rev. Cancer 2004, 4:850-860.
25. Puga A., Xia Y., Elferink C. Role of the aryl hydrocarbon receptor in cell cycle regulation. Chem. Biol. Interact. 2002, 141:117-130.
26. Sangrajrang S., et al. Genetic polymorphisms of estrogen metabolizing enzyme and breast cancer risk in Thai women. Int. J. Cancer 2009, 125:837-843.
27. Shin A., et al. Meat intake, heterocyclic amine exposure, and metabolizing enzyme polymorphisms in relation to colorectal polyp risk. Cancer Epidemiol. Biomarkers Prev. 2008, 17:320-329.
28. Siegel R., Ward E., Brawley O., Jemal A. Cancer Statistics, 2011: The Impact of Eliminating Socioeconomic and Racial Disparities on Premature Cancer Deaths 2011.
29. Wang H., et al. Genetic variation in the bioactivation pathway for polycyclic hydrocarbons and heterocyclic amines in relation to risk of colorectal neoplasia. Carcinogenesis 2011, 32:203-209.
30. Whitlock J.J. Induction of cytochrome P4501A1. Annu. Rev. Pharmacol. Toxicol. 1999, 39:103-125.
31. Zhang D.S., Lin G.F., Ma Q.W., Shen J.H. Nonassociation of aryl hydrocarbon receptor genotypes with susceptibility to bladder cancer in Shanghai population. Acta Pharmacol. Sin. 2002, 23:188-192.
32. Zhang B., et al. Evaluation of functional genetic variants for breast cancer risk: results from the Shanghai breast cancer study. Am. J. Epidemiol. 2011, 173:1159-1170.